Tucson Medical Center v. Purdue Pharma LP et al
| Tucson Medical Center |
| Purdue Frederick Company Incorporated, Purdue Pharma LP, Abbott Laboratories, Mallinckrodt LLC, Mallinckrodt PLC, Anda Incorporated, Allergan PLC, Purdue Pharma Incorporated, Insys Therapeutics Incorporated, Actavis LLC, Amneal Pharmaceuticals LLC, Cephalon Incorporated, H.D. Smith LLC, Henry Schein Incorporated, Janssen Pharmaceutica Incorporated, Endo Health Solutions Incorporated, Teva Pharmaceuticals USA Incorporated, Depomed Incorporated, Johnson & Johnson, Actavis Pharma Incorporated, Endo Pharmaceuticals Incorporated, Watson Laboratories Incorporated, Cardinal Health Incorporated, AmerisourceBergen Drug Corporation, Abbott Laboratories Incorporated, Ortho-McNeil-Janssen Pharmaceuticals Incorporated, Watson Pharmaceuticals Incorporated, Specgx LLC, Noramco Incorporated, Janssen Pharmaceuticals Incorporated, CVS Pharmacy Incorporated, CVS Pharmacies, CVS Health Corporation, CVS Arizona LLC, H.D. Smith Wholesale Drug Company, Actavis PLS and Watson Pharma Incorporated |
| 4:2019cv00358 |
| July 15, 2019 |
| US District Court for the District of Arizona |
| Raner C Collins |
| Lynnette C Kimmins |
| Other Statutes: Racketeer/Corrupt Organization |
| 28 U.S.C. § 1441 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 23, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 43 Mail Returned as Undeliverable. Mail sent to Gerald M Abdalla. Reason for return: Attempted - Not Known, Unable to Forward. Document number #41 . (SST) |
| Filing 42 NOTICE of filing the Acknowledged Receipt of Order to Remand from Pima County Superior Court. (BAR) |
Filing 41
ORDER By United States Judicial Panel on Multidistrict Litigation. That the Panel's Conditional Transfer Order Designated as "CTO-105" filed on July 31, 2019, is VACATED. (MAP)
|
|
Filing 40
ORDER: Plaintiff's Emergency Motion to Remand and For Sanctions (Doc. #1 ) is GRANTED IN PART AND DENIED IN PART. The request for remand is granted. The request for sanctions is denied. This case shall be remanded to the Superior Court of Pima County, Arizona. The Clerk of the Court is ordered to close the Court's file in this matter. Signed by Senior United States District Judge Raner C Collins. (MCO)
|
| Filing 39 Corporate Disclosure Statement by Anda Incorporated. (Hall, Carlyle) |
| Remark: Pro hac vice motions granted for Katy E Koski, James W Matthews, and Ana M Francisco on behalf of Anda Incorporated. This is a TEXT ENTRY ONLY. There is no PDF document associated with this entry. (BAS) |
| Filing 38 Corporate Disclosure Statement by Noramco Incorporated. (Sperling, Elizabeth) |
| Filing 37 Corporate Disclosure Statement by Johnson & Johnson. (Johnston, Bradley) |
| Filing 36 Corporate Disclosure Statement by Janssen Pharmaceuticals Incorporated. (Johnston, Bradley) |
| Filing 35 Corporate Disclosure Statement by Endo Health Solutions Incorporated, Endo Pharmaceuticals Incorporated identifying Corporate Parent Endo International, plc for Endo Health Solutions Incorporated, Endo Pharmaceuticals Incorporated. (Jackson, G) |
| Filing 33 REPLY to Response to Motion re: #1 Emergency MOTION to Remand to State Court And For Sancttions MOTION to Expedite Tucson Medical Center's Emergency Motion to Remand filed by Tucson Medical Center. (Attachments: #1 Exhibit Ex. A - Transcript, #2 Exhibit Ex. B - Email, #3 Exhibit Ex. C - Insys MTD Below, #4 Exhibit Ex. D - Insys Joining All Manufacturer Defendants MTD Below, #5 Exhibit Ex. E - Indefinite Delay, #6 Exhibit Ex F - "Its like people are addicted to these things or something. Oh, wait, people are...", #7 Exhibit Ex. G - Compliance with the law is a "business" decision, #8 Exhibit Ex. H - Knowledge of Child Addiction)(Mitchell, Samuel) |
| Remark: Pro hac vice motion granted for John P McDonald on behalf of Henry Schein Incorporated. This is a TEXT ENTRY ONLY. There is no PDF document associated with this entry. (BAS) |
| Filing 34 Mail Returned as Undeliverable. Mail sent to Gerald M. Abdalla. Reason for return: Return to Sender, Not Deliverable as Forward. Document number 11. (BAR) |
| Filing 31 Corporate Disclosure Statement by Henry Schein Incorporated. (Weisman, Adam) |
|
Filing 30
ORDERED that this matter is reassigned to the Honorable Raner C. Collins. Signed by Magistrate Judge Lynnette C Kimmins on 7/30/19. (CKS)
|
| Filing 29 Corporate Disclosure Statement by Watson Pharmaceuticals Incorporated. (Stein, Lee) |
| Filing 28 Corporate Disclosure Statement by Allergan PLC. (Stein, Lee) |
| Filing 27 Corporate Disclosure Statement by H.D. Smith LLC identifying Corporate Parent AmerisourceBergen Corporation for H.D. Smith LLC. (Kastner, John) |
| Filing 26 Corporate Disclosure Statement by AmerisourceBergen Drug Corporation identifying Corporate Parent AmerisourceBergen Services Corporation, Corporate Parent AmerisourceBergen Corporation for AmerisourceBergen Drug Corporation. (Kastner, John) |
| Filing 22 Corporate Disclosure Statement by Cardinal Health Incorporated. (Stillwell, Karen) |
| Filing 21 Corporate Disclosure Statement by Tucson Medical Center. (Mitchell, Steven) |
| Filing 20 Corporate Disclosure Statement by Actavis LLC, Actavis Pharma Incorporated, Cephalon Incorporated, Teva Pharmaceuticals USA Incorporated, Watson Laboratories Incorporated. (Davis, Gregory) |
| Remark: Pro hac vice motions granted for Samuel Mitchell and John W Barrett on behalf of plaintiff Tucson Medical Center, granted for Daniel Jarcho for defendant Noramco Incorporated, and granted for Kathleen Matsoukas and William Edward Padgett on behalf of HD Smith LLC. This is a TEXT ENTRY ONLY. There is no PDF document associated with this entry. (BAS) |
| Filing 25 Party Elects Assignment of Case to District Judge Jurisdiction. This is a TEXT ENTRY ONLY. There is no PDF document associated with this entry. (BAC) |
| Filing 18 Corporate Disclosure Statement by Purdue Frederick Company Incorporated, Purdue Pharma Incorporated, Purdue Pharma LP identifying Corporate Parent Pharmaceutical Research Associates Incorporated for Purdue Frederick Company Incorporated. (Benveniste, Katherine) |
| Filing 17 RESPONSE in Opposition re: #1 Emergency MOTION to Remand to State Court And For Sancttions MOTION to Expedite Tucson Medical Center's Emergency Motion to Remand filed by Actavis LLC, Actavis Pharma Incorporated, Cephalon Incorporated, Teva Pharmaceuticals USA Incorporated, Watson Laboratories Incorporated. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Davis, Gregory) |
| Filing 12 REPORT of Defendants' Notice of Pending Motions by Defendants Janssen Pharmaceuticals Incorporated, Johnson & Johnson. (Johnston, Bradley) |
|
Filing 11
ORDER granting #8 Motion to Expedite Briefing and Ruling on Plaintiff's Emergency Motion to Remand and for Sanctions. IT IS FURTHER ORDERED that Defendants shall respond to Plaintiff's motion (Doc. #1 ) on or before July 26, 2019. Plaintiff shall file its reply on or before July 31, 2019. Signed by Magistrate Judge Lynnette C Kimmins on 7/18/2019. (DLC)
|
| Filing 10 NOTICE of Errata re: #2 Notice of Removal by Defendants Actavis LLC, Actavis Pharma Incorporated, Cephalon Incorporated, Teva Pharmaceuticals USA Incorporated, Watson Laboratories Incorporated.. (Davis, Gregory) |
| Filing 9 NOTICE re: Tucson Medical Center's Notice of Related Action by Tucson Medical Center . (Mitchell, Steven) |
| Filing 8 Emergency MOTION to Expedite Plaintiff's Emergency Motion to Remand and For Sanctions by Tucson Medical Center. (Attachments: #1 Exhibit Ex A - LRCiv 3.6(c) Notice, #2 Exhibit Ex B - Pima County Superior Court Minute Entry Taking Motions Under Advisement)(Mitchell, Steven) |
| Filing 7 NOTICE TO PARTY RE: CORPORATE DISCLOSURE STATEMENT: Pursuant to FRCiv 7.1 and LRCiv 7.1.1 the attached Corporate Disclosure Statement form must be filed by all nongovernmental corporate parties with their first appearance. A supplemental statement must be filed upon any change in the information. In addition, if not already filed, the Corporate Disclosure Statement should be filed within 14 days. Corporate Disclosure Statement Deadline set as to Abbott Laboratories, Abbott Laboratories Incorporated, Allergan PLC, AmerisourceBergen Drug Corporation, Amneal Pharmaceuticals LLC, Anda Incorporated, Cardinal Health Incorporated, Depomed Incorporated, Endo Health Solutions Incorporated, Endo Pharmaceuticals Incorporated, H.D. Smith LLC, Henry Schein Incorporated, Insys Therapeutics Incorporated, Janssen Pharmaceutica Incorporated, Janssen Pharmaceuticals Incorporated, Johnson & Johnson, Mallinckrodt LLC, Mallinckrodt PLC, Noramco Incorporated, Ortho-McNeil-Janssen Pharmaceuticals Incorporated, Purdue Frederick Company Incorporated, Purdue Pharma Incorporated, Purdue Pharma LP, Specgx LLC, Tucson Medical Center. (KAH) |
| Filing 6 NOTICE TO PARTY OF DEFICIENCY RE: CORPORATE DISCLOSURE STATEMENT: Pursuant to FRCiv 7.1 and LRCiv 7.1.1 the attached Corporate Disclosure Statement form must be filed by all nongovernmental corporate parties with their first appearance. A supplemental statement must be filed upon any change in the information. In addition, if not already filed, the Corporate Disclosure Statement should be filed within 14 days. Corporate Disclosure Statement Deadline set as to Actavis LLC, Actavis Pharma Incorporated, Cephalon Incorporated, Teva Pharmaceuticals USA Incorporated, Watson Laboratories Incorporated, Watson Pharmaceuticals Incorporated. (KAH) |
| Filing 5 NOTICE TO THE PARTIES - The Court is participating in the Mandatory Initial Discovery Pilot (MIDP) and this case is subject to that pilot. The key features and deadlines are set forth in the attached Notice which includes General Order 17-08. Also attached is a checklist for use by the parties. All parties must respond to the mandatory initial discovery requests set forth in the General Order before initiating any further discovery in this case. Please note: The discovery obligations in the General Order supersede the disclosures required by Rule 26(a)(1). Any party seeking affirmative relief must serve a copy of the attached documents (Notice to Parties, including General Order 17-08 and MIDP Checklist) on each new party when the Complaint, Counterclaim, Crossclaim, or Third-Party Complaint is served. (KAH) |
| Filing 4 NOTICE TO FILER OF DEFICIENCY re: Document not in compliance with LRCiv 7.1(a)(3) - Party names must be capitalized using proper upper and lower case type. No further action is required. This is a TEXT ENTRY ONLY. There is no PDF document associated with this entry. (KAH) |
| Filing 1 Emergency MOTION to Remand to State Court And For Sancttions, MOTION to Expedite Tucson Medical Center's Emergency Motion to Remand by Tucson Medical Center. (Attachments: #1 Exhibit Exhibit A, #2 Exhibit Exhibit B, #3 Exhibit Exhibit C, #4 Exhibit Exhibit D, #5 Exhibit Exhibit E, #6 Exhibit Exhibit F)(Mitchell, Steven) |
| Filing 3 Filing fee paid, receipt number 0970-17164382. This case has been assigned to the Honorable Lynnette C Kimmins. All future pleadings or documents should bear the correct case number: CV-19-358-TUC-LCK. Magistrate Election form attached. PLEASE NOTE: Plaintiff(s) and defendants that have already appeared in this case are required to file the attached Magistrate Election form within FOURTEEN (14) days of this filing. Please read attached instructions. (KAH) |
| Filing 2 NOTICE OF REMOVAL from Pima County Superior Court, case number C20184991. Filing fee received: $ 400.00, receipt number 0970-17164382 filed by Specgx LLC, Cephalon Incorporated, Actavis Pharma Incorporated, Mallinckrodt LLC, Actavis LLC, Mallinckrodt PLC, Watson Laboratories Incorporated, Ortho-McNeil-Janssen Pharmaceuticals Incorporated, Janssen Pharmaceutica Incorporated, Teva Pharmaceuticals USA Incorporated, Janssen Pharmaceuticals Incorporated, Johnson & Johnson, Noramco Incorporated. (Davis, Gregory) (Attachments: #1 Civil Cover Sheet, #2 Civil Cover Sheet Supplemental, #3 Exhibit A, #4 Exhibit B, #5 Exhibit C, #6 Exhibit D, #7 Exhibit E part 1, #8 Exhibit E part 2, #9 Exhibit E part 3, #10 Exhibit E part 4, #11 Exhibit E part 5, #12 Exhibit E part 6, #13 Exhibit E part 7, #14 Exhibit E part 8, #15 Exhibit E part 9, #16 Exhibit E part 10, #17 Exhibit E part 11, #18 Exhibit E part 12, #19 Exhibit E part 13, #20 Exhibit E part 14, #21 Exhibit E part 15, #22 Exhibit E part 16, #23 Exhibit E part 17, #24 Exhibit E part 18, #25 Exhibit E part 19, #26 Exhibit E part 20, #27 Exhibit F)(KAH) |
| ***STATE COURT RECORD RECEIVED*** SERVICE EXECUTED of Original Complaint: Affidavit of Service re: Summons, Civil Cover Sheet with Attachment, Complaint and Motion to Designate Action as Complex upon Johnson & Johnson, Janssen Pharmaceuticals Incorporated, Ortho-McNeil-Janssen Pharmaceuticals Incorporated, Janssen Pharmaceutica Incorporated, Endo Pharmaceuticals Incorporated, H.D. Smith LLC, Endo Health Solutions Incorporated and Amneal Pharmaceuticals LLC on 10/11/2018 (original filed in Pima County Superior Court on 10/15/2018); Affidavit of Service re: Summons, Civil Cover Sheet with Attachment, Complaint and Motion to Designate Action as Complex upon Allergan PLC, Actavis LLC, Cephalon Incorporated, Anda Incorporated, Watson Pharmaceuticals Incorporated and Watson Pharmaceuticals Incorporated on 10/11/2018 (original filed in Pima County Superior Court on 10/17/2018); Affidavit of Service of Process re: Summons, Civil Cover Sheet with Attachment, Complaint and Motion to Designate Action as Complex upon Actavis Pharma Incorporated, Watson Laboratories Incorporated and Teva Pharmaceuticals USA Incorporated on 10/10/2018 (original filed in Pima County Superior Court on 10/18/2018); Amended Affidavit of Service of Process re: Summons, Civil Cover Sheet with Attachment, Complaint and Motion to Designate Action as Complex upon Abbott Laboratories, Purdue Pharma LP, Henry Schein Incorporated, Cardinal Health Incorporated, AmerisourceBergen Drug Corporation, Insys Therapeutics Incorporated and Abbott Laboratories Incorporated on 10/10/2018 (original filed in Pima County Superior Court on 10/18/2018); Affidavit of Service of Process re: Summons, Civil Cover Sheet with Attachment, Complaint and Motion to Designate Action as Complex upon Specgx LLC, Mallinckrodt LLC and Mallinckrodt PLC on 10/11/2018 (original filed in Pima County Superior Court on 10/19/2018); Affidavit of Service of Process re: Summons, Civil Cover Sheet with Attachment, Complaint and Motion to Designate Action as Complex upon Depomed Incorporated and Noramco Incorporated on 10/15/2018 (original filed in Pima County Superior Court on 10/23/2018); Affidavit of Service of Process re: Summons, Civil Cover Sheet with Attachment, Complaint and Motion to Designate Action as Complex upon Purdue Pharma Incorporated and Purdue Frederick Company Incorporated on 10/11/2018 (original filed in Pima County Superior Court on 10/23/2018.)(KAH) This is a TEXT ENTRY ONLY. There is no PDF document associated with this entry. |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Arizona District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
